Exosens SAS

ENXTPA:EXENS Stock Report

Market Cap: €1.9b

Exosens SAS Future Growth

Future criteria checks 3/6

Exosens SAS is forecast to grow earnings and revenue by 18.5% and 11.5% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

18.5%

Earnings growth rate

18.11%

EPS growth rate

Aerospace & Defense earnings growth13.1%
Revenue growth rate11.5%
Future return on equity16.81%
Analyst coverage

Good

Last updated03 Sep 2025

Recent future growth updates

Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Aug 03
Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Mar 06
€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Recent updates

Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Aug 03
Exosens (EPA:EXENS) Released Earnings Last Week And Analysts Lifted Their Price Target To €41.21

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Jul 25
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 26% Above Its Share Price

Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Jul 06
Exosens (EPA:EXENS) Might Have The Makings Of A Multi-Bagger

Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly

Jun 13
Exosens (EPA:EXENS) Seems To Use Debt Quite Sensibly
User avatar

Elevated Defense Spending Will Challenge Overvaluation And Unleash Upside

Growth and profitability expectations rely on sustained global defense spending, rapid demand capture, and seamless operational execution, making them vulnerable to defense cycle shifts and integrati

Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

May 29
Market Participants Recognise Exosens' (EPA:EXENS) Revenues Pushing Shares 27% Higher

€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Mar 06
€31.58 - That's What Analysts Think Exosens (EPA:EXENS) Is Worth After These Results

Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Mar 05
Optimistic Investors Push Exosens (EPA:EXENS) Shares Up 37% But Growth Is Lacking

Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Feb 14
Exosens' (EPA:EXENS) Intrinsic Value Is Potentially 96% Above Its Share Price

Earnings and Revenue Growth Forecasts

ENXTPA:EXENS - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202758898931456
12/31/202652785721287
12/31/202547067461065
6/30/20254325657101N/A
3/31/2025413415699N/A
12/31/2024394265596N/A
9/30/2024374144885N/A
6/30/2024354-34074N/A
3/31/202432323062N/A
12/31/202329272050N/A
12/31/202220112647N/A
12/31/2021166-1492343N/A
12/31/2020150-163044N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EXENS's forecast earnings growth (18.5% per year) is above the savings rate (1.9%).

Earnings vs Market: EXENS's earnings (18.5% per year) are forecast to grow faster than the French market (12% per year).

High Growth Earnings: EXENS's earnings are forecast to grow, but not significantly.

Revenue vs Market: EXENS's revenue (11.5% per year) is forecast to grow faster than the French market (5.2% per year).

High Growth Revenue: EXENS's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EXENS's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/03 06:07
End of Day Share Price 2025/09/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Exosens SAS is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laurent GelebartBNP Paribas Exane
Charles ArmitageCitigroup Inc
David PerryJ.P. Morgan